247 related articles for article (PubMed ID: 25695315)
1. Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring.
Nakagawa-Goto K; Oda A; Hamel E; Ohkoshi E; Lee KH; Goto M
J Med Chem; 2015 Mar; 58(5):2378-89. PubMed ID: 25695315
[TBL] [Abstract][Full Text] [Related]
2. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić J; Ríos-Luci C; Karpaviciene I; Cikotiene I; Fernandes MX; Pešić M; Padrón JM
Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
[TBL] [Abstract][Full Text] [Related]
3. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
[TBL] [Abstract][Full Text] [Related]
4. Antitubulin effects of aminobenzothiophene-substituted triethylated chromones.
Kobayashi Y; Saito Y; Goto M; Nakagawa-Goto K
Bioorg Med Chem Lett; 2017 Jun; 27(12):2731-2735. PubMed ID: 28457756
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors.
Shobeiri N; Rashedi M; Mosaffa F; Zarghi A; Ghandadi M; Ghasemi A; Ghodsi R
Eur J Med Chem; 2016 May; 114():14-23. PubMed ID: 26974371
[TBL] [Abstract][Full Text] [Related]
6. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 284. New desmosdumotin B analogues with bicyclic B-ring as cytotoxic and antitubulin agents.
Nakagawa-Goto K; Wu PC; Lai CY; Hamel E; Zhu H; Zhang L; Kozaka T; Ohkoshi E; Goto M; Bastow KF; Lee KH
J Med Chem; 2011 Mar; 54(5):1244-55. PubMed ID: 21284385
[TBL] [Abstract][Full Text] [Related]
8. Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative.
Sawada JI; Ishii H; Matsuno K; Sato M; Suzuki Y; Asai A
Mol Pharmacol; 2019 Nov; 96(5):609-618. PubMed ID: 31471455
[TBL] [Abstract][Full Text] [Related]
9. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
Maklad RM; AbdelHafez EMN; Abdelhamid D; Aly OM
Bioorg Chem; 2020 Jun; 99():103767. PubMed ID: 32325332
[TBL] [Abstract][Full Text] [Related]
10. (Z)-1-aryl-3-arylamino-2-propen-1-ones, highly active stimulators of tubulin polymerization: synthesis, structure-activity relationship (SAR), tubulin polymerization, and cell growth inhibition studies.
Reddy MV; Akula B; Cosenza SC; Lee CM; Mallireddigari MR; Pallela VR; Subbaiah DR; Udofa A; Reddy EP
J Med Chem; 2012 Jun; 55(11):5174-87. PubMed ID: 22587519
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of colchicine B-ring analogues tethered with halogenated benzyl moieties.
Cosentino L; Redondo-Horcajo M; Zhao Y; Santos AR; Chowdury KF; Vinader V; Abdallah QM; Abdel-Rahman H; Fournier-Dit-Chabert J; Shnyder SD; Loadman PM; Fang WS; Díaz JF; Barasoain I; Burns PA; Pors K
J Med Chem; 2012 Dec; 55(24):11062-6. PubMed ID: 23176628
[TBL] [Abstract][Full Text] [Related]
12. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
[TBL] [Abstract][Full Text] [Related]
13. Novel colchicine-site binders with a cyclohexanedione scaffold identified through a ligand-based virtual screening approach.
Canela MD; Pérez-Pérez MJ; Noppen S; Sáez-Calvo G; Díaz JF; Camarasa MJ; Liekens S; Priego EM
J Med Chem; 2014 May; 57(10):3924-38. PubMed ID: 24773591
[TBL] [Abstract][Full Text] [Related]
14. PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors.
Martínez-Díez M; Guillén-Navarro MJ; Pera B; Bouchet BP; Martínez-Leal JF; Barasoain I; Cuevas C; Andreu JM; García-Fernández LF; Díaz JF; Avilés P; Galmarini CM
Biochem Pharmacol; 2014 Apr; 88(3):291-302. PubMed ID: 24486569
[TBL] [Abstract][Full Text] [Related]
15. Triethylated chromones with substituted naphthalenes as tubulin inhibitors.
Nakagawa-Goto K; Taniguchi Y; Watanabe Y; Oda A; Ohkoshi E; Hamel E; Lee KH; Goto M
Bioorg Med Chem; 2016 Nov; 24(22):6048-6057. PubMed ID: 27707623
[TBL] [Abstract][Full Text] [Related]
16. Discovery of potent cytotoxic ortho-aryl chalcones as new scaffold targeting tubulin and mitosis with affinity-based fluorescence.
Zhu C; Zuo Y; Wang R; Liang B; Yue X; Wen G; Shang N; Huang L; Chen Y; Du J; Bu X
J Med Chem; 2014 Aug; 57(15):6364-82. PubMed ID: 25061803
[TBL] [Abstract][Full Text] [Related]
17. Indirubin, a bis-indole alkaloid binds to tubulin and exhibits antimitotic activity against HeLa cells in synergism with vinblastine.
Mohan L; Raghav D; Ashraf SM; Sebastian J; Rathinasamy K
Biomed Pharmacother; 2018 Sep; 105():506-517. PubMed ID: 29883946
[TBL] [Abstract][Full Text] [Related]
18. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
19. Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor.
Hsu LC; Durrant DE; Huang CC; Chi NW; Baruchello R; Rondanin R; Rullo C; Marchetti P; Grisolia G; Simoni D; Lee RM
Invest New Drugs; 2012 Aug; 30(4):1379-88. PubMed ID: 21655917
[TBL] [Abstract][Full Text] [Related]
20. Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting with tubulin and overcomes ABC transporter-mediated drug resistance.
Aoyama A; Katayama R; Oh-Hara T; Sato S; Okuno Y; Fujita N
Mol Cancer Ther; 2014 Dec; 13(12):2978-90. PubMed ID: 25313010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]